Navigation Links
New Studies Confirm Safety, Effectiveness of Balloon Sinuplasty(TM) Technology for Chronic Sinusitis
Date:9/21/2008

Patients show significant improvement through 2-year follow-up

MENLO PARK, Calif., Sept. 22 /PRNewswire/ -- Two multicenter studies published this week in Otolaryngology - Head and Neck Surgery confirm Balloon Sinuplasty(TM) technology is safe and effective when used by physicians to treat chronic sinusitis patients.

The foundation for those studies was a six-month clinical trial called CLEAR that began in 2005. It included 109 patients who had minimally invasive sinus surgery with the Balloon Sinuplasty(TM) technology. They participated in one-year and two-year follow-up studies which reported:

-- 92% functional patency at one-year follow-up.

-- At two-year follow-up, 85% of patients reported improvement in their

sinus symptoms. No patient's condition worsened.

-- Clinically and statistically significant improvements in patient

quality of life maintained at one and two year follow-up.

-- No serious adverse events observed at any time point throughout the

study.

Balloon Sinuplasty(TM) technology is used to restore normal sinus drainage by widening constricted sinus passages with specially designed catheters and balloons. The technology has been used to treat over 40,000 patients since receiving FDA clearance in 2005 and can be used alone or with standard surgical instrumentation.

The Center for Disease Control data reports sinusitis is among the most common illnesses in the U.S., affecting an estimated 37 million Americans and leading to 500,000 surgeries a year. Symptoms include repeated infections, headaches, facial pain, persistent congestion and unrelenting fatigue.

"The goal of sinus surgery is to open the sinuses so they can function normally, while preserving as much natural anatomy as possible. With Balloon Sinuplasty(TM) technology, we are able to accomplish that goal with our current approach in a true minimally invasive way, and give our patients the r
'/>"/>

SOURCE Acclarent, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. InNexus Lead Candidate DXL625 Outperforms Rituxan in Additional Animal Studies
2. Most Cancer Treatment Studies Arent Published, Study Finds
3. Bionovo Reports on Metabolic Studies Related to Its Menopausal Hot Flash Drug Candidate
4. Nutrition 21 Reports That National Toxicology Program Studies Support the Safety of Chromium Picolinate
5. Phase III Clinical Studies of Aclidinium Bromide Show Statistical Significance vs. Placebo in Patients With Chronic Obstructive Pulmonary Disease (COPD)
6. Catheter Ablation System for Atrial Fibrillation Shows Reduced Procedure Time, Remarkable Safety Profile and Excellent Outcomes in Two Clinical Studies
7. Genmab Announces Upcoming Ofatumumab Studies
8. Pooled-Analysis of 54 Clinical Studies Shows No Increased Risk of Heart Attack With Abacavir Therapy
9. Isolagen, Inc. Reports Positive Top-line Results from Pivotal Phase III Studies of Isolagen Therapy(TM) in Wrinkles: Studies Meet All Primary Efficacy Endpoints and are Statistically Significant
10. Treatment Corrects Severe Insulin Imbalance in Animal Studies
11. Video: Resveratrol-based Nutriceutical (Longevinex(R)) Induces Favorable Changes on Gene Expression in Mouse Heart At Doses 17-320 Times Lower Than Prior Studies

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/25/2009)..., Mass., Nov. 25 Hologic...a leading developer, manufacturer and supplier of ...urgical products dedicated to serving the healthca...the Radiological Society of North America (RSNA) a...December 3, 2009 to highlight our new SecurView(&#...
(Date:11/25/2009)...DELPHIA, Nov. 25 ERT (Na... McKelvey, the Company,s President and CEO, and Ke...t and CFO, are scheduled to present at the 21st An...PM EST on December 1, 2009 in New York City, New Y...ntation by visiting the Company,s corporate websit...
(Date:11/25/2009)...., Nov. 25 BioTrends Research Grou... : Stelara report, the first in a multi-phase ...unch of Centocor Ortho-Biotech,s Stelara, from pro...bility. Each wave of the report provides quantita... qualitative information from a subset of 20. The...
Breaking Medicine Technology:New Hologic SecurView(R) DX Diagnostic Workstation Software Streamlines Workflow, Improves Radiologist Productivity 2New Hologic SecurView(R) DX Diagnostic Workstation Software Streamlines Workflow, Improves Radiologist Productivity 3New Hologic SecurView(R) DX Diagnostic Workstation Software Streamlines Workflow, Improves Radiologist Productivity 4ERT to Present at the 21st Annual Piper Jaffray Health Care Conference on December 1, 2009 2Despite Managed Care Obstacles, Interest and Anticipated Use of Centocor Ortho-Biotech's New Psoriasis Agent Stelara (ustekinumab) is High 2New ways to predict violent behavior 3F 58345 1New ways to predict violent behavior 3F 58345 2Bodys immune system response to dental plaque varies by gender and race 58342 1Bodys immune system response to dental plaque varies by gender and race 58342 2Research needed to learn which DCIS patients may be candidates for less invasive therapy 10105 1Research needed to learn which DCIS patients may be candidates for less invasive therapy 10105 2Research needed to learn which DCIS patients may be candidates for less invasive therapy 10105 3
...TH, N.J., May 15 Schering-Plough,Corporation (NYS...reatment of,chronic hepatitis C virus (HCV) infect...al studies with PEGINTRON(TM) (peginterferon alfa-...erapy, as well as boceprevir, the,company,s invest...sented at,the 39th annual Digestive Disease Week (...
...R, Mich. and TOULOUSE, France, May 15 Cerenis,The...tical company,developing HDL-related compounds for...eases, today announced that it has completed a Pha...y,s lead product candidates.,CER-002 is a peroxiso...ecific agonist in development for the treatment of...
Other Medicine Technology:Schering-Plough Highlights PEGINTRON(TM) and Boceprevir Hepatitis C Data Presentations at Digestive Disease Week (DDW) Annual Meeting 2Schering-Plough Highlights PEGINTRON(TM) and Boceprevir Hepatitis C Data Presentations at Digestive Disease Week (DDW) Annual Meeting 3Schering-Plough Highlights PEGINTRON(TM) and Boceprevir Hepatitis C Data Presentations at Digestive Disease Week (DDW) Annual Meeting 4Schering-Plough Highlights PEGINTRON(TM) and Boceprevir Hepatitis C Data Presentations at Digestive Disease Week (DDW) Annual Meeting 5Schering-Plough Highlights PEGINTRON(TM) and Boceprevir Hepatitis C Data Presentations at Digestive Disease Week (DDW) Annual Meeting 6Schering-Plough Highlights PEGINTRON(TM) and Boceprevir Hepatitis C Data Presentations at Digestive Disease Week (DDW) Annual Meeting 7Cerenis Therapeutics Completes Phase I Clinical Trial of CER-002 for Treatment of Cardiovascular Disease 2
(Date:11/26/2009)... Research Triangle Dental (RTDental...h Carolina, today announced the expansion of its s...ER Dentist, Dr. Doug Macmillan. , ...e Dental is pleased to announce that Dr. Doug Macm...y completed an additional advanced training semina...
(Date:11/26/2009)... Ennis & Ennis, P.A. is offerin...sers of Yaz and Yasmin birth control pills who hav... Embolism, Stroke, Heart Attack or other related c...men can call toll free at 1-800-856-6405 or go to ...om and fill out an online case evaluation form. ...
(Date:11/25/2009)..., KANSAS CITY, Mo., Nov. 25 The B...me the nation,s largest medical clinic on Dec. 9-1...f massive free clinics for uninsured people. ,,...he biggest one yet, because it will extend over tw... instead of over a weekend," Sheri Wood, executive...
(Date:11/25/2009)..., TORONTO and CALGARY, Nov. 25 /PRNewswire/ - Sen...gnetic Resonance Imaging (MRI) coils and software ... software enabling technologies, have introduced a...lization software. ,, This innovative interface...d medical imaging offering in the market. Calgary ...
(Date:11/25/2009)..., LONG BEACH, Calif., Nov. 25 Than...1,000 homebound seniors in the greater Long Beach ...r Aging, a program operated by Independence at Hom...than 17 years these organizations have gathered hu...meals to seniors in need in Long Beach, Lakewood, ...
Breaking Medicine News(10 mins):Health News:Dr. Douglas Macmillan Now Providing LUMINEERS at Research Triangle Dental 2Health News:Ennis & Ennis, P.A. Announces Nationwide Free, Confidential, Consultations For Users Of Yaz And Yasmin Birth Control Pills 2Health News:Ennis & Ennis, P.A. Announces Nationwide Free, Confidential, Consultations For Users Of Yaz And Yasmin Birth Control Pills 3Health News:Kansas City Prepares for Largest Free Health Clinic 2Health News:Sentinelle Medical Inc. Introduces Aegis(TM) Web Powered By Calgary Scientific's PureWeb Technology 2Health News:Sentinelle Medical Inc. Introduces Aegis(TM) Web Powered By Calgary Scientific's PureWeb Technology 3Health News:SCAN Employees and Community Volunteers to Help Deliver One Thousand Thanksgiving Meals to Homebound Seniors 2
... study published in the February issue of the Jour...al infection does raise the risk of developing pre...y also indicate that preeclamptic mothers have low... group by almost 64 percent than the non-preeclamp...
...aram, a 55-year-old man in the Indian State of Mad...t 20 years due to a mental illness. // He spends m...s family members. Mansharam was chained after he s...one its best to get him treated, but this did not ...
...irect implantation of stem cells into the pancreas...enhance the production of endogenous insulin. // I...e in the C Peptide levels, and a subsequent decrea... drugs to stimulate the production of insulin. It ...
...overnment is spending large amount of money on the...rnment has to act quickly otherwise the // problem...s are currently rising and is as high as 16% of gr...s and the federal government employees. The proces...
...ood and Drug Administration has allowed the counte...as available only if the patient possesses a presc...lts showed that this drug helped in the reduction ... effects such as gas, incontinence and oily spotti...
...tists belonging to India’s National Institute of I...tant element which helps us to understand how the ...ody. // This will help in developing newer and mo...khale have identified the genes that enable the my...
Other Medicine News:Health News:Gum Disease Associated With Increased Risk of Preeclampsia 2Health News:Demand For Diet Drugs On The Rise 2
Single-Piece Intraocular Lens with haptic eyelets
NaturaLens™ Series Hydrophobic Acrylic Intraocular Lens (Refractive and Bifocal)
STABIBAG Hydrophilic Acrylic Lens
Raysoft Foldable Intraocular Lens
Medicine Products: